In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 85 for your search:
Keywords/Phrases:  cholangiocarcinoma
Trial Status:  Active
Start Over
        Show
1.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 1111012021, NCT01524146

2.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 19 and over
Sponsor: Other
Protocol IDs: R11-153, 117354, NCT01673802

3.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: CHOLANGIO01, CHOLANGIO100513, NCT01920503

4.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GATCO-1, NCT01043172

5.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SUMS-5010, Cholangiocarcinoma, Surgery, Drainage, NCT00797121

6.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PIN-PHO1201, NCT02082522

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: RFA2012, NCT01739465

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 90
Sponsor: Other
Protocol IDs: XHDD-004, NCT02108145

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: GOX-P, S-20080081, 2612-3769, NCT00779454

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: SUN-CK D09-2, 2011-000073-30, NCT01718327

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H2009/3522, NCT00973713

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-020385-13, NCT01206049

13.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2372P, NCT01549795

14.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 05-0651 / 201102096, NCT00301379

15.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2252P, NCT01442324

16.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1110011999, NCT01755013

17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-16236, NCT01253148

18.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 08I5, STU00007062, NCI-2009-01122, NCT00858429

19.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 30 to 65
Sponsor: Other
Protocol IDs: P-09-00171, NCT01039181

20.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 201111068, NCT01525069

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-EB-CHOL-Th, 2012-001213-16, A121007-71, NCT01912053

22.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 17 to 60
Sponsor: Other
Protocol IDs: EHBH-RCT-2013-002-02, NCT01914289

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 11-0181, NCT01648023

24.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-1345 / 201107319, NCT01668134

25.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09-131, P01CA021239, NCT00976898
1     
New Search